1. Acute cystitis in men– a nationwide study from primary care: antibiotic prescriptions, risk factors, and complications.
- Author
-
Sætre, Håkon, Skow, Marius, Vik, Ingvild, Høye, Sigurd, and Emilsson, Louise
- Subjects
ANTIBIOTICS ,DIABETES complications ,MEN ,RISK assessment ,NITROFURANTOIN ,MEDICAL prescriptions ,RESEARCH funding ,DATA analysis ,FLUOROQUINOLONES ,PRIMARY health care ,CYSTITIS ,LOGISTIC regression analysis ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,DECISION making in clinical medicine ,PROSTATE tumors ,REPORTING of diseases ,BENIGN prostatic hyperplasia ,RETENTION of urine ,STATISTICS ,TREATMENT failure ,TRIMETHOPRIM ,DISEASE relapse ,DATA analysis software ,CONFIDENCE intervals ,PENICILLIN ,SENSITIVITY & specificity (Statistics) ,REGRESSION analysis ,SULFAMETHOXAZOLE ,DISEASE risk factors ,DISEASE complications - Abstract
Background: Research on acute cystitis in men is scarce and treatment guidelines differ between countries. Improved antibiotic stewardship is needed. Aim: To analyse antibiotic prescriptions and outcomes of Norwegian men diagnosed with cystitis in primary care. Design & setting: A nationwide retrospective study was undertaken in primary care in Norway. Method: We identified all episodes of acute cystitis in men diagnosed in Norwegian primary care during 2012–2019. Choice of antibiotic (from the Norwegian Prescription Database), treatment failure, re-prescription, and complications were stratified by age, calendar year, and risk factors. We used logistic regression to explore predefined risk factors (diabetes, prostate cancer, benign prostate hyperplasia [BPH], urinary retention, and any cancer) with complications (pyelonephritis, prostatitis, and hospitalisation) and re-prescriptions. Linear regression was used to explore time trends. Results: In total, 108 994 individuals contributed 148 635 episodes. Narrow-spectrum antibiotics were first-choice treatment in 71.0% of the episodes (52.5% of all prescriptions were pivmecillinam). More than 75% of the episodes with narrow-spectrum versus 82.2% of broad-spectrum treatment did not lead to any re-prescription or complication. Complications occurred in 1.8% of all episodes (0.5% prostatitis, 0.7% pyelonephritis, and 0.7% hospitalisation). BPH was associated with increased risk of complications and re-prescription. Diabetes was associated with a lower risk of re-prescriptions. Prostate cancer and urinary retention were associated with a lower risk of both complications and re-prescriptions. Conclusion: Our results support narrow-spectrum antibiotics as first-line treatment. Risk factor analyses warrants further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF